The content on this site is intended for healthcare professionals only
Dr Giuliani talks to ecancertv at ICMM 2016 about his research on myeloma bone disease.
He explains how tumours prevent bones from repairing and describes the plight of patients with fractures and bone pain.
Thus far, the treatment has been bisphosphonates, but there are new drugs on the horizon that may have a positive effect on bone remodelling, he says, such as the combination of monoclonal antibodies and immunotherapy drugs.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Best practice in precision medicine for prostate cancer
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
Isatuximab with VRd can benefit newly diagnosed multiple myeloma transplant ineligible patients
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Latest in EGFR mutated NSCLC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
